MDA-9/Syntenin (SDCBP) Is a Critical Regulator of Chemoresistance, Survival and Stemness in Prostate Cancer Stem Cells

Despite some progress, treating advanced prostate cancer remains a major clinical challenge. Recent studies have shown that prostate cancer can originate from undifferentiated, rare, stem cell-like populations within the heterogeneous tumor mass, which play seminal roles in tumor formation, maintena...

Descripción completa

Detalles Bibliográficos
Autores principales: Talukdar, Sarmistha, Das, Swadesh K., Pradhan, Anjan K., Emdad, Luni, Windle, Jolene J., Sarkar, Devanand, Fisher, Paul B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7017101/
https://www.ncbi.nlm.nih.gov/pubmed/31878027
http://dx.doi.org/10.3390/cancers12010053

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7017101/
https://www.ncbi.nlm.nih.gov/pubmed/31878027
http://dx.doi.org/10.3390/cancers12010053

Ejemplares similares